ProCE Banner Activity

Insights From AIDS 2024: Optimizing ART in Australia

Clinical Thought

Learn how data from the AIDS 2024 conference shows that switching can be safe and effective for people with viral suppression, even those with a history of resistance associated mutations. 

Released: August 20, 2024

Expiration: August 19, 2025

Share

Faculty

Don E Smith

Don E Smith, MD, FRCP (London) FAChSHM

Senior Staff Specialist
Conjoint Professor
School of Clinical Medicine
University of New South Wales
Albion Centre
Sydney, Australia

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society  

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS

ProCE Banner

Disclosure

Primary Author

Don E Smith, MD, FRCP (London) FAChSHM

Senior Staff Specialist
Conjoint Professor
School of Clinical Medicine
University of New South Wales
Albion Centre
Sydney, Australia

Don E. Smith, MD, FRCP (London) FAChSHM: consultant/advisor/speaker: Gilead, ViiV.

Presenter

Angela Davies, MD

Assistant Professor of Medicine
UC Davis Cancer Center
Sacramento, CA